- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT00792064
Systematic Evaluation of Predictors of Quality of Life in the Long-term After Solid Organ Transplantation
August 24, 2009 updated by: Hannover Medical School
Systematic Evaluation of Predictors of Quality of Life in the Long-term After Solid Organ Transplantation- a Prospective Cohort Study
A systematic evaluation of predictors of health related quality of life (HRQoL) leads to multiple level of data analysis.
The aim of the herein described observational project is to create a transplant patients registry on psychosocial outcomes and to evaluate longitudinally predictors of HRQoL after different types of solid organ transplantation in the long-term.
A sample size of 700 participants consisting of all solid organ types is envisioned.
Data will be compared with published healthy normative data.
Data Evaluation of predictors of HRQoL may guide development of tailored interventions to reduce complications and to further improve outcomes.
Study Overview
Status
Unknown
Conditions
Study Type
Observational
Enrollment (Anticipated)
700
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
-
Hannover, Germany, 30625
- Recruiting
- Hannover Medical School, Clinic für cardias, thoracic, transplantation and vascular surgery
-
Contact:
- Christiane Kugler
- Phone Number: 0049-511-5326586
- Email: kugler.christiane@mh-hannover.de
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years to 70 years (Adult, Older Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Sampling Method
Probability Sample
Study Population
patients immediately after solid organ transplantation
Description
Inclusion Criteria:
- Follow-up at our outpatient clinics
- Written informed consent
- Sufficient German language skills to read and answer a battery of questionnaires
- Min 18 years
Exclusion Criteria:
- Illiteracy
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
Cohorts and Interventions
Group / Cohort |
|---|
|
1
Kidney-Tx-recipients
|
|
2
Liver-Tx-recipients
|
|
3
Heart-Tx-recipients
|
|
4
Lung-Tx-recipients
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Time Frame |
|---|---|
|
HRQoL after transplantation
Time Frame: 5 yrs
|
5 yrs
|
Secondary Outcome Measures
Outcome Measure |
Time Frame |
|---|---|
|
Social re-integration
Time Frame: 5 yrs
|
5 yrs
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Collaborators
Investigators
- Principal Investigator: Christiane Kugler, PhD, Clinic for Cardiac, Thoracic, Transplantation and
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
February 1, 2009
Primary Completion (Anticipated)
December 1, 2013
Study Completion (Anticipated)
July 1, 2014
Study Registration Dates
First Submitted
November 14, 2008
First Submitted That Met QC Criteria
November 14, 2008
First Posted (Estimate)
November 17, 2008
Study Record Updates
Last Update Posted (Estimate)
August 25, 2009
Last Update Submitted That Met QC Criteria
August 24, 2009
Last Verified
August 1, 2009
More Information
Terms related to this study
Keywords
Other Study ID Numbers
- IRB No_378
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.